New deal... Pfizer pays Resapp the hundred odd million for the covid data set as well as the management team and they get none of the tech, DX or sleepcheck.
Half the money is then redistributed to SH in the form of a one off special dividend and the rest goes back into the business.
Ann: Increased Scheme Consideration from Pfizer, page-342
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #